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Abstract
Primary rhabdomyosarcoma of the prostate is a malignancy primarily of pediatric age group with
most cases seen during infancy and childhood. Majority present with urinary symptoms but the case
we report here presented at 16 years of age and had unusually nonspecific and temporally protracted
nature of symptoms prior to the presentation. This remarkable unusualness lead to a delay in
presentation and contributed to an eventually unfavorable outcome.
Introduction
Primary embryonal prostatic rhabdomyosarcoma (EPRM)
is an uncommon tumor and most cases, as reported in the
past, present early in age and with predominant lower
urinary tract symptoms [1,2]. We report a case which is
unusual for its conspicuous absence of urinary symptoms
or lymphadenopathy in spite of the widespread disease at
presentation. The relatively nonspecific constitutional and
protracted complaints of fever and polyarthralgias mas-
querading like that of a systemic illness, lead to a delayed
presentation and poor prognosis for the patient.
Case presentation
A 16-year-old Asian-Indian male student presented with
progressively worsening dyspnea on exertion and new
onset skin nodules over past one week. He has had
polyarthralgias and low grade fever of two months
duration. Past and personal history was unremarkable
for any significant illness, allergy or high-risk behavior.
Patient had received broad spectrum antibiotics prior to
the admission for his constitutional symptoms without
any clinical benefit. On examination the patient was
febrile, pale, normotensive with sinus tachycardia, and
had multiple non-tender subcutaneous nodules, two to
four centimeters in size, predominantly on the scalp, face
and upper trunk. He also had scattered crackles all over the
chest, mild splenomegaly and non-tender prostate enlar-
gement. Investigations showed normocytic normochromic
anemia, hypercalcemia and hyperuricemia. Routine uri-
nalysis was normal. No laboratory evidence of tubercu-
losis, immuno-compromised state or an autoimmune
disorder was observed. Chest imaging (Figure 1) showed
multiple bilateral nodular densities. Patient was hydrated,
transfused blood products and put on an empirical broad
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spectrum antibiotic cover pending blood and urine culture
reports which eventually turned out to be sterile.
Computed tomography of abdomen unveiled an inciden-
tal, 6 × 5 × 5 cm homogenous soft tissue mass rising from
prostrate. The prostate specific antigen (PSA) and prostatic
acid phosphatase (PAP) were within normal limits. Trucut
biopsy (of forehead nodule) was done; the microscopy
and immuno-histochemistry suggested an embryonal
rhabdomyosarcoma (Figure 2). Patient subsequently was
found to have multiple osteolytic lesions in the skull,
pelvis and proximal long bones. In view of a metastatic
prostatic embryonal rhabdomyosarcoma the patient was
started on vincristine, adriamycin and cyclophosphamide
regimen. After a transient initial clinical response the
patient succumbed to complications of widespread disease
after 3 weeks. An autopsy could not be consented for by
the patient’s relatives.
Discussion
Embryonal prostatic rhabdomyosarcoma that occurs
predominantly in male infants and children (median age
of 5 years) is a rare and highly malignant tumour. Only
sporadic cases have been reported in non-pediatric age
group [1,2,3].
Characteristic features of EPRM published in literature
include rapidly progressive obstructive urinary symptoms,
smooth and firm enlargement of prostate on digital rectal
examination, occasional suprapubic mass, regional lymph
node spread, respiratory symptoms due to metastasis to
lungs, osteoclastic bone metastases, and normal prostatic
acid phosphates and prostate specific antigen levels
[1,2,3]. The case presented here is atypical in terms of its
inconspicuous presentation mimicking a systemic inflam-
matory response and in the authors’ best knowledge has
not been reported before. Although primary site in prostate
is a favorable prognostic sign for rhabdomyosarcomas,
the presence of detectable metastases, tumor size > 5
centimeters and age > 10 years at presentation were the
associated poor prognostic features in our patient which
explains the unfortunate outcome [4]. Tumor debulking
(excising ≥ 50 % of tumor) followed by chemotherapy has
improved overall survival rates to 75% in EPRM patients,
but our patient had distant detectable spread at the time
of presentation which precluded any form of surgical
intervention [5].
Conclusion
Embryonal rhabdomyosarcoma of prostate in non-pedia-
tric age group may have non specific presentation. It is
prudent to have a high index of suspicion in diagnosing
such cases early to avert grave prognosis.
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Consent
Written informed consent for publication of this case
report could not be obtained. The patient died and the
next of kin were lost to follow up. Extensive attempts made
to obtain consent proved futile. Anonymity of the patient
has been thoroughly maintained in this case report. We
would not expect the patient's family to object to
publication.
Figure 1. CECT chest (lung window) shows multiple
varying nodules in both lungs.
Figure 2. (H/E-400X) showing a malignant small round cell
tumor with frequent mitosis and there is no evidence of any
differentiation. Immunohistochemistry reveals focal
cytoplasmic positivity for desmin and negativity for leukocyte
common antigen, cytokeratin, chromogranin, MIC-2 and
S-100 protein. The histological and histochemistry findings
are compatible with undifferentiated rhabdomyosarcoma.
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